Various labeling systems are currently being used by U.S. retailers and food makers to make nutritional claims. Barbara Schneeman, Ph.D., director of the FDA’s Office of Nutrition, Labeling and Dietary Supplements, recently sent an open letter to the food industry stating the agency’s intent to develop a new regulation to define “the nutritional criteria that […]
There’s an old adage, “Any publicity is good publicity,” but the exposure of four New Jersey lawmakers on the front page of the New York Times was anything but good news for them. The article reported that Menaflex, a medical device that reinforces damaged knee tissue, was approved only after the two senators and two […]
In the US, preparations for Swine Flu center entirely on a new and untested vaccine along with anti-viral drugs that don’t work very well and have serious side effects. The Canadian government by contrast is willing to consider some other, common sense alternatives.
ANH-USA has filed three lawsuits against the FDA in recent weeks. In each case, we have been joined as plaintiffs by dietary supplement formulators Durk Pearson and Sandy Shaw and the Coalition to End FDA and FTC Censorship. We are being represented by the law firm of Emord & Associates.
On May 1, the US Food and Drug Administration (FDA) issued a warning letter to consumers to stop using Hydroxycut. The line of products was pulled from the market after reports of liver damage and one death, though those reports have yet to be documented.
In 2005, an up-and-coming pharmaceutical company made a big mistake: they invested millions of dollars into developing a drug only to discover that the only active ingredient of the drug, pyridoxamine, was really a common, naturally occurring substance that has been sold for decades at low cost to consumers in the form of a dietary […]
Scientists say the naturally occurring antioxidant lycopene, found in abundance in tomatoes, helps block the body from absorbing “bad” LDL cholesterol. This bad cholesterol is primarily responsible for clogging arteries.
The proposed budget of the US Food and Drug Administration (FDA) is worrying the Democrats. They are concerned that FDA’s annual increases in industry user fees—$828 million from manufacturers of medical and food products, including hundreds of millions drug manufacturers pay annually to help speed the review of new medicines—might compromise the agency’s independence.
The Project on Government Oversight, an independent watchdog group that exposes problems in government, has learned that the Food and Drug Administration (FDA) has quietly reduced their enforcement of federal quality regulations at laboratories that develop medical devices. The FDA’s inspections of “good laboratory practices” dropped dramatically in the past few years: from 33 in […]
Ralph Moss, PhD, author of the CancerDecision newsletter, has brought attention to a proposed change in Medicare rules regarding payment of anticancer drugs.